Susan Hasty, Publisher
Table of Contents . . . May 12th, 2008
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Clinical Trial Research - Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
Lupus - Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
Memory Pharmaceuticals Corp. - Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
Nymox Pharmaceutical Corporation - Nymox Announces New Positive Results at 54 Months in Long Term Study of NX-1207 for Benign Prostatic Hyperplasia
Acute Myelogenous Leukemia - Reports outline acute myelogenous leukemia research from University of Medicine and Dentistry of New Jersey
Adenocarcinoma - Research from Cornell University provide new insights into adenocarcinoma
Adverse Drug Reactions - Study results from Princess Margaret Hospital broaden understanding of adverse drug reactions
Atrial Fibrillation - Scientists at University of Montreal target atrial fibrillation
Breast Cancer - New breast cancer research reported from Duke University
Breast Cancer - New breast cancer study findings reported from L.Y. Dirix and co-authors
Breast Cancer - Researchers at Osaka National Hospital publish new data on breast cancer
Breast Cancer - Studies from National Cancer Institute yield new data on breast cancer
Breast Cancer - Study results from University of Texas update understanding of breast cancer
Cancer - New cancer research has been reported by R.J. Amato et al
Cancer - New findings from National Cancer Institute in the area of cancer published
Cancer Vaccines - Research on cancer vaccines described by D. Atanackovic and colleagues
Cancer Vaccines - Research reports on cancer vaccines from E.N. Vinageras and colleagues provide new insights
Chronic Lymphocytic Leukemia - Studies from University of Texas provide new data on chronic lymphocytic leukemia
Clinical Trial Research - Research from Queen's University broadens understanding of clinical trial research
Clinical Trial Research - Research from University of California reveals new findings on clinical trial research
Cord Blood - Data on cord blood discussed by R.L. Haspel and colleagues
Epilepsy - Studies from University of California yield new data on epilepsy
Gastrointestinal Stromal Tumors - Data from C.D. Blanke et al provide new insights into gastrointestinal stromal tumors
Hormones - Data from J. Spona et al provide new insights into hormones
Lung Cancer - Research on lung cancer detailed by scientists at University of Maryland
Mesothelioma - Studies from Brigham and Women's Hospital provide new data on mesothelioma
Monoclonal Antibodies - Data on monoclonal antibodies described by researchers at Duke University
Monoclonal Antibodies - Research results from University of Texas update knowledge of monoclonal antibodies
Monoclonal Antibodies - Study results from University of Paris provide new insights into monoclonal antibodies
Myeloid Leukemia - New research on myeloid leukemia from University of Texas summarized
Non-Hodgkin Lymphoma - Data on non-hodgkin lymphoma described by researchers at University of Rochester
Non-Hodgkin Lymphoma - Research from A. Krishnan and co-authors in the area of non-hodgkin lymphoma published
Non-Small Cell Lung Cancer - Findings from University of North Carolina in non-small cell lung cancer reported
Non-Small Cell Lung Cancer - New findings from Y. Oh and co-researchers in the area of non-small cell lung cancer described
Non-Small Cell Lung Cancer - Reports by R. Lilenbaum and co-researchers describe recent advances in non-small cell lung cancer
Non-Small Cell Lung Cancer - Research reports from N.A. Rizvi and co-authors provide new insights into non-small cell lung cancer
Non-Small Cell Lung Cancer - Study results from H. Kunitoh and colleagues update understanding of non-small cell lung cancer
Ovarian Cancer - Research from University of California provide new insights into ovarian cancer
Pancreatic Cancer - Research from Northwestern University yields new data on pancreatic cancer
Small Cell Lung Cancer - Study findings on small cell lung cancer are outlined in reports from Johns Hopkins University
Solid Cancer - Research on solid cancer published by scientists at Indiana University
Adenovirus - Research from University of Pittsburgh, Pittsburgh Cancer Institute reveals new findings on adenovirus
Cancer Therapy - Recent findings from Mayo Clinic highlight research in cancer therapy
Cancer Therapy - Reports outline cancer therapy study results from University of Cagliari, Department of Medical Oncology
Cancer Therapy - Research results from Technical University of Munich, Department of Medicine update knowledge of cancer therapy
Cancer Vaccines - Data on cancer vaccines reported by researchers at University of Virginia, Division of Surgical Oncology
Central Nervous System Disorders Therapy - Studies from Duke University, Department of Medical Oncology have provided new data on central nervous system disorders therapy
Melanoma Clinical Trial - Data on melanoma clinical trial published by researchers at University Hospital, Department of Dermatology
Melanoma Therapy - Studies from University of Montpellier, Department of Dermatology reveal new findings on melanoma therapy
Nephrectomy - Investigators at Medical University of Vienna zero in on nephrectomy
Non-Small Cell Lung Cancer Therapy - New non-small cell lung cancer therapy study findings recently were published by researchers at Chinese University of Hong Kong, Cancer Institute
Prostate Cancer Therapy - Research from University of Wisconsin, Comprehensive Cancer Center yields new findings on prostate cancer therapy
Accentia Biopharmaceuticals, Inc. - SinuNase Fast-Tracked Pivotal Phase 3 Study in Chronic Sinusitis Shows Statistically Significant Objective Evidence of Superiority of SinuNase Over Control Lavage in Severe Cases
Acorda Therapeutics, Inc. - Acorda Therapeutics Reports First Quarter 2008 Financial Results
Alexza Pharmaceuticals, Inc. - Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
Amgen - Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory Committee Meeting in June
AmpliMed Corporation - AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer
Antigenics Inc. - Antigenics Reports First Quarter 2008 Financial Results
Apotex Inc., Kwizda Pharma GmbH and Intas Biopharmaceuticals Limited - Biosimilar G-CSF: Cooperation on Three Continents.
BioLineRx Ltd. - BioLineRx Presents BL-1020 Phase 2a Data at Society of Biological Psychiatry 63rd Annual Scientific Convention & Meeting
Breast Cancer - Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
Bronchiectasis - Regulatory Path for Bronchitol in Bronchiectasis
Cambridge Consultants - Cambridge Consultants Offers Fast Track to Phase I Clinical Trials for Inhalable Drugs with Development Support for Conix
Cancer - Alan S. Schwartz Elected Chair, Karmanos Cancer Institute Board of Directors
Cancer - Oncothyreon files investigational new drug application for PX-866 oncology compound
Clinical Trial Research - Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
Coagulation - Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
Cougar Biotechnology, Inc. - Cougar Biotechnology Announces Initiation of Phase III Trial of CB7630 Abiraterone Acetate
Curis, Inc. - Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer
Curis, Inc. - Curis Reports First Quarter 2008 Financial Results
Emergent BioSolutions Inc. - Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate and Technology
Hepatitis C Virus - Clinical Update - Debio 025 in Hepatitis C
Hepatitis C Virus - Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Hepatitis C Virus - Roche's Investigational Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Response in Phase IIa Study
KaloBios Pharmaceuticals, Inc. - KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003
Kosan Biosciences Incorporated - Kosan Announces First Quarter 2008 Financial Results
La Jolla Pharmaceutical Company - La Jolla Pharmaceutical Company Reports First Quarter Financial Results
Lux Biosciences, Inc. - Lux Biosciences' Presentations at ARVO Highlight Both Topical and Polymer Delivery Technologies Targeting Chronic Inflammatory Ocular Diseases
Marketing and Licensing Agreements - Neuromed Names Sean Cunliffe Chief Commercial Officer
Medtronic, Inc. - Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Melanoma - Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
Metabasis Therapeutics, Inc. - Metabasis Therapeutics Announces Positive Results in the Phase 2a Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes
Multiple Sclerosis - Merck Serono Announces Initiation of Phase II Clinical Trial of Atacicept in Relapsing Multiple Sclerosis
NACHA - International Payments Framework Now in Phase II
Nuon Therapeutics Inc. - Nuon Therapeutics Inc. Completes $27 Million Series B Financing
Oculus Innovative Sciences, Inc. - Oculus Innovative Sciences Announces Initial Chinese Commercialization Plan for Launch of Microcyn Technology
Panic Disorder - Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
Protez Pharmaceuticals - Protez Initiates Phase II Study for Its Lead Product PZ-601 in Infectious Diseases
Pulmo BioTech Inc. - Pulmo BioTech Announces Appointment of Chief Financial Officer
Regeneron Pharmaceuticals, Inc. - Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
Schering-Plough Corporation - Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
Small Cell Lung Cancer - Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors
Type 2 Diabetes - Spherix D-tagatose to be Supplied by Inalco SpA
ZymoGenetics, Inc. - Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis
ZymoGenetics, Inc. - ZymoGenetics Presents Positive Results from RECOTHROM Thrombin, topical Recombinant Spray Study in Burn Patients
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.